435 related articles for article (PubMed ID: 22155112)
1. The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.
Horváth B; Mukhopadhyay P; Haskó G; Pacher P
Am J Pathol; 2012 Feb; 180(2):432-42. PubMed ID: 22155112
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.
Di Marzo V; Piscitelli F; Mechoulam R
Handb Exp Pharmacol; 2011; (203):75-104. PubMed ID: 21484568
[TBL] [Abstract][Full Text] [Related]
3. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic opportunities through modulation of the endocannabinoid system.
Makriyannis A; Mechoulam R; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1068-71. PubMed ID: 15885714
[No Abstract] [Full Text] [Related]
5. Cannabinoids.
Grotenhermen F
Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
7. [News about therapeutic use of Cannabis and endocannabinoid system].
Duran M; Laporte JR; Capellà D
Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
Karanian DA; Bahr BA
Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications.
Kumawat VS; Kaur G
Eur J Pharmacol; 2019 Nov; 862():172628. PubMed ID: 31461639
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system: a new perspective for cardiometabolic risk control.
Francischetti EA; de Abreu VG
Arq Bras Cardiol; 2006 Oct; 87(4):548-58. PubMed ID: 17128328
[No Abstract] [Full Text] [Related]
11. Role of the endocannabinoid system in diabetes and diabetic complications.
Gruden G; Barutta F; Kunos G; Pacher P
Br J Pharmacol; 2016 Apr; 173(7):1116-27. PubMed ID: 26076890
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
Michalski CW; Laukert T; Sauliunaite D; Pacher P; Bergmann F; Agarwal N; Su Y; Giese T; Giese NA; Bátkai S; Friess H; Kuner R
Gastroenterology; 2007 May; 132(5):1968-78. PubMed ID: 17484889
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids, endocannabinoids, and cancer.
Hermanson DJ; Marnett LJ
Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid system as an emerging target of pharmacotherapy.
Pacher P; Bátkai S; Kunos G
Pharmacol Rev; 2006 Sep; 58(3):389-462. PubMed ID: 16968947
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
17. Modulating the endocannabinoid system in human health and disease--successes and failures.
Pacher P; Kunos G
FEBS J; 2013 May; 280(9):1918-43. PubMed ID: 23551849
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L; Bisogno T; Di Marzo V
Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
[TBL] [Abstract][Full Text] [Related]
19. Psychopharmacology of the endocannabinoids: far beyond anandamide.
Pamplona FA; Takahashi RN
J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
[TBL] [Abstract][Full Text] [Related]
20. The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses.
Bisogno T; Di Marzo V
Curr Pharm Des; 2008; 14(23):2299-3305. PubMed ID: 18781980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
